143 related articles for article (PubMed ID: 1552234)
1. Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis.
Lindstedt KA; Kokkonen JO; Kovanen PT
J Lipid Res; 1992 Jan; 33(1):65-75. PubMed ID: 1552234
[TBL] [Abstract][Full Text] [Related]
2. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
Kovanen PT
Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
[TBL] [Abstract][Full Text] [Related]
3. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
Kovanen PT
Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
[TBL] [Abstract][Full Text] [Related]
4. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.
Kokkonen JO; Kovanen PT
Biochem J; 1987 Jan; 241(2):583-9. PubMed ID: 3593208
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein.
Kokkonen JO; Kovanen PT
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2287-91. PubMed ID: 3470793
[TBL] [Abstract][Full Text] [Related]
6. Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor.
Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):837-44. PubMed ID: 8382053
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro.
Kokkonen JO; Kovanen PT
J Biol Chem; 1989 Jun; 264(18):10749-55. PubMed ID: 2659592
[TBL] [Abstract][Full Text] [Related]
8. Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells.
Serafin WE; Katz HR; Austen KF; Stevens RL
J Biol Chem; 1986 Nov; 261(32):15017-21. PubMed ID: 3095324
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of low density lipoproteins by rat serosal mast cells.
Kokkonen JO; Kovanen PT
Eur Heart J; 1990 Aug; 11 Suppl E():134-46. PubMed ID: 2226522
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a high-affinity heparin subfraction with low-density lipoprotein stimulates cholesteryl ester accumulation in mouse macrophages.
Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1991 Jan; 1081(2):188-96. PubMed ID: 1998737
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of macrophage-mediated low density lipoprotein oxidation by stimulated rat serosal mast cells.
Lindstedt KA
J Biol Chem; 1993 Apr; 268(11):7741-6. PubMed ID: 8463303
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
Paananen K; Kovanen PT
J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis of mast cell granule remnant-bound LDL by smooth muscle cells of synthetic phenotype: a scavenger receptor-mediated process that effectively stimulates cytoplasmic cholesteryl ester synthesis.
Wang Y; Lindstedt KA; Kovanen PT
J Lipid Res; 1996 Oct; 37(10):2155-66. PubMed ID: 8906593
[TBL] [Abstract][Full Text] [Related]
14. Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfated chondroitin sulfate proteoglycans.
Katz HR; Austen KF; Caterson B; Stevens RL
J Biol Chem; 1986 Oct; 261(29):13393-6. PubMed ID: 3531203
[TBL] [Abstract][Full Text] [Related]
15. IgE-dependent generation of foam cells: an immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages.
Ma H; Kovanen PT
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):811-9. PubMed ID: 7773738
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs.
Ma H; Kovanen PT
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E134-42. PubMed ID: 11116078
[TBL] [Abstract][Full Text] [Related]
17. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
Atkins FM; Metcalfe DD
J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of copper-mediated oxidation of LDL by rat serosal mast cells. A novel cellular protective mechanism involving proteolysis of the substrate under oxidative stress.
Lindstedt KA; Kokkonen JO; Kovanen PT
Arterioscler Thromb; 1993 Jan; 13(1):23-32. PubMed ID: 8422337
[TBL] [Abstract][Full Text] [Related]
19. Modification of low density lipoproteins by secretory granules of rat serosal mast cells.
Kovanen PT; Kokkonen JO
J Biol Chem; 1991 Mar; 266(7):4430-6. PubMed ID: 1999427
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages.
Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
Arterioscler Thromb; 1992 Feb; 12(2):237-49. PubMed ID: 1543697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
